Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (491-500 of 742) with videos related to

Pageof 75
Sort By:
Neurobiology of Disease|November 14, 2015
A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer's diseaseKaitlin M Moore, Renee E Girens, Sara K Larson, et al.
Nature|May 25, 2012
Apolipoprotein E controls cerebrovascular integrity via cyclophilin ARobert D Bell, Ethan A Winkler, Itender Singh, et al.
The Journal of Clinical Investigation|January 19, 2008
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer diseaseSuzanne E Wahrle, Hong Jiang, Maia Parsadanian, et al.
Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometryTomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.
Journal of Alzheimer'S Disease : JAD|July 8, 2009
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic miceChuanhai Cao, John R Cirrito, Xiaoyang Lin, et al.
Nature|May 4, 2023
Author Correction: Apolipoprotein E controls cerebrovascular integrity via cyclophilin ARobert D Bell, Ethan A Winkler, Itender Singh, et al.
JAMA Neurology|September 15, 2015
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer DiseaseMaartje I Kester, Charlotte E Teunissen, Daniel L Crimmins, et al.
Human Molecular Genetics|July 24, 2012
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Petra Nowotny, et al.
Neuron|May 12, 2020
SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain InjuryAndrew D Sauerbeck, Mihika Gangolli, Sydney J Reitz, et al.
The Journal of Biological Chemistry|May 13, 2005
The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP miceJohn D Fryer, Ronald B Demattos, Lynn M McCormick, et al.
Pageof 75

Showing results (491-500 of 742) with videos related to

Sort By:
Pageof 75
Neurobiology of Disease|November 14, 2015
A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer's diseaseKaitlin M Moore, Renee E Girens, Sara K Larson, et al.
Nature|May 25, 2012
Apolipoprotein E controls cerebrovascular integrity via cyclophilin ARobert D Bell, Ethan A Winkler, Itender Singh, et al.
The Journal of Clinical Investigation|January 19, 2008
Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer diseaseSuzanne E Wahrle, Hong Jiang, Maia Parsadanian, et al.
Rapid Communications in Mass Spectrometry : RCM|November 23, 2006
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometryTomoyuki Oe, Bradley L Ackermann, Koichi Inoue, et al.
Journal of Alzheimer'S Disease : JAD|July 8, 2009
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic miceChuanhai Cao, John R Cirrito, Xiaoyang Lin, et al.
Nature|May 4, 2023
Author Correction: Apolipoprotein E controls cerebrovascular integrity via cyclophilin ARobert D Bell, Ethan A Winkler, Itender Singh, et al.
JAMA Neurology|September 15, 2015
Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer DiseaseMaartje I Kester, Charlotte E Teunissen, Daniel L Crimmins, et al.
Human Molecular Genetics|July 24, 2012
Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Petra Nowotny, et al.
Neuron|May 12, 2020
SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain InjuryAndrew D Sauerbeck, Mihika Gangolli, Sydney J Reitz, et al.
The Journal of Biological Chemistry|May 13, 2005
The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP miceJohn D Fryer, Ronald B Demattos, Lynn M McCormick, et al.
Pageof 75